Literature DB >> 21437017

The current status of thrombopoietins in the management of liver disease.

Hans L Tillmann1.   

Abstract

Entities:  

Year:  2010        PMID： 21437017      PMCID： PMC3033539     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

Authors:  John G McHutchison; Geoffrey Dusheiko; Mitchell L Shiffman; Maribel Rodriguez-Torres; Samuel Sigal; Marc Bourliere; Thomas Berg; Stuart C Gordon; Fiona M Campbell; Dickens Theodore; Nicole Blackman; Julian Jenkins; Nezam H Afdhal
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

Review 2.  Biology and chemistry of thrombopoietic agents.

Authors:  David J Kuter
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

Review 3.  Use of thrombopoietic agents for the thrombocytopenia of liver disease.

Authors:  Hans L Tillmann; John G McHutchison
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

4.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

Review 5.  Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C.

Authors:  Geoffrey Dusheiko
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

Review 6.  Novel thrombopoietic agents.

Authors:  Biree Andemariam; Bethan Psaila; James B Bussel
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

Review 7.  Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Clin Chim Acta       Date:  2007-02-27       Impact factor: 3.786
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.